- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PYY1-36 sitagliptin
Total 1011 results
-
Garvan Institute of Medical ResearchCompleted
-
Johns Hopkins UniversityMerck Sharp & Dohme LLCTerminatedGlucose HomeostasisUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Tehran University of Medical SciencesCompletedUncontrolled Type 2 Diabetes MellitusIran, Islamic Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, Puerto Rico, United Kingdom, Ireland, Germany, Slovenia, Canada, France, Italy, Spain, Netherlands, Slovakia, Romania, Former Serbia and Montenegro
-
University Medical Centre LjubljanaCompletedPolycystic Ovary Syndrome | Body Weight
-
Royal Adelaide HospitalMerck Sharp & Dohme LLCCompletedDiabetes Mellitus | GastroparesisAustralia
-
Merck Sharp & Dohme LLCCompletedRenal Insufficiency | Hemodialysis
-
Seoul National University Bundang HospitalCompletedDiabetesKorea, Republic of
-
Samuel Lunenfeld Research Institute, Mount Sinai...Merck Sharp & Dohme LLCCompleted
-
AstraZenecaCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Xiangya Hospital of Central South UniversityRecruiting
-
GeNeuro Innovation SASCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Korea, Republic of, Latvia, Peru, Lithuania, Israel, Norway, Finland, Argentina, Austria, Belgium, Germany, Greece, Guatemala, Hungary, India, Italy, Mexico, Poland, Romania, Slovakia, Venezuela
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Singapore
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Germany, United States, France, United Kingdom
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Peru, Israel, Taiwan, Australia, Russian Federation, United Kingdom, Korea, Republic of, Spain, Brazil, Colombia, India, Philippines, South Africa
-
India Diabetes Research Foundation & Dr. A. Ramachandran...Withdrawn
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Niigata Medical CenterNagaoka Red Cross HospitalUnknownType 2 DiabetesJapan
-
Ono Pharmaceutical Co. LtdCompletedType 2 Diabetes MellitusJapan
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Belgium, Canada, France, India, Italy, Korea, Republic of, Malaysia, Netherlands, Spain
-
Konya Beyhekim Training and Research HospitalNot yet recruiting
-
Centre Hospitalier Universitaire de BesanconActive, not recruiting
-
Universidad de GuanajuatoHospital Regional de Alta Especialidad del BajioUnknownInsulin Resistance | Prediabetic StateMexico
-
Kaiser PermanentePatient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaboratorsRecruitingCardiovascular Diseases | Type 2 Diabetes MellitusUnited States
-
Konya Beyhekim Training and Research HospitalNot yet recruiting
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
vTv TherapeuticsCompleted
-
AstraZenecaCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Mexico, Guatemala
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Brazil, Canada, El Salvador, France, Korea, Republic of, New Zealand, Norway, Spain, Taiwan
-
Boehringer IngelheimCompleted
-
Kallyope Inc.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
University of Southern CaliforniaCompletedInflammation | AtherosclerosisUnited States
-
Merck Sharp & Dohme LLCCompleted
-
University of British ColumbiaMerck Sharp & Dohme LLCTerminatedIslet TransplantationCanada
-
Medical College of WisconsinMerck Sharp & Dohme LLCCompletedDiabetes | AtherosclerosisUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
Boehringer IngelheimCompleted
-
Bezmialem Vakif UniversityCompleted
-
Boryung Pharmaceutical Co., LtdCompleted
-
AstraZenecaCompleted